Skip to main content
Figure 2 | BMC Ophthalmology

Figure 2

From: Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial

Figure 2

Mean IOP at baseline and after 6 weeks of treatment with TRAV vs BIM. (a) Mean ± SD IOP across time points (i.e., mean of 4, 6, and 8 pm assessments). (b) Mean IOP at individual time points (TRAV, n = 80 at the 4 and 8 pm time points). BIM = bimatoprost 0.01%; IOP = intraocular pressure; TRAV = benzalkonium chloride–free travoprost 0.004%.

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us